{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:07:55Z","timestamp":1770919675681,"version":"3.50.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,9]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Ogden syndrome is an exceptionally rare X-linked disease caused by mutations in the NAA10 gene. Reported cases of this syndrome are approximately 20 children and are associated with facial dysmorphism, growth delay, developmental disorders, congenital heart disease, and arrhythmia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We present the clinical profile of a 3-year-old girl with Ogden syndrome carrying a de novo NAA10 variant [NM_003491:c.247C&gt;T, p.(Arg83Cys)]. During infancy, she exhibited features such as left ventricular hypertrophy, protruding eyeballs, and facial deformities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Clinical diagnosis included Ogden syndrome, congenital heart disease (obstructive hypertrophic cardiomyopathy, left ventricular outflow tract obstruction, mitral valve disease, tricuspid valve regurgitation), tonsillar and adenoidal hypertrophy, and speech and language delay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The girl was considered to have hypertrophic cardiomyopathy (HCM) and received oral metoprolol as a treatment for HCM at our hospital. The drug treatment effect was not ideal, and her hypertrophy myocardial symptoms were aggravated and she had to be hospitalized for surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The girl underwent a modified Morrow procedure under cardiopulmonary bypass and experienced a favorable postoperative recovery. No pulmonary infections or significant complications were observed during this period. The patient\u2019s family expressed satisfaction with the treatment process.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The case emphasizes the HCM of Odgen syndrome, and early surgery should be performed if drug treatment is ineffective.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000036034","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:28Z","timestamp":1707509188000},"page":"e36034","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["NAA10 gene related Ogden syndrome with obstructive hypertrophic cardiomyopathy: A rare case report"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3594-6621","authenticated-orcid":false,"given":"Feihong","family":"Li","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Children\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Children\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazhou","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Huadong Hospital, Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Children\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Children\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Children\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3188-3731","authenticated-orcid":false,"given":"Yaoqin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Children\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/ajmg.a.62351","article-title":"Confirmation of Ogden syndrome as an X-linked recessive fatal disorder due to a recurrent NAA10 variant and review of the literature.","volume":"185","author":"Gogoll","year":"2021","journal-title":"Am J Med Genet A"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/humu.23001","article-title":"Expanding the phenotype associated with NAA10-Related N-Terminal acetylation deficiency.","volume":"37","author":"Saunier","year":"2016","journal-title":"Hum Mutat"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1074\/mcp.M113.035402","article-title":"A Saccharomyces cerevisiae model reveals in vivo functional impairment of the Ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant.","volume":"13","author":"Van Damme","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/genes12060900","article-title":"Clinical manifestations in a girl with NAA10-related syndrome and genotype-phenotype correlation in females.","volume":"12","author":"Maini","year":"2021","journal-title":"Genes (Basel)"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ajhg.2011.05.017","article-title":"Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency.","volume":"89","author":"Rope","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pediatrneurol.2017.07.010","article-title":"Clinical manifestations associated with the N-terminal-acetyltransferase NAA10 gene mutation in a girl: Ogden syndrome.","volume":"76","author":"Sidhu","year":"2017","journal-title":"Pediatr Neurol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/eurheartj\/ehl041","article-title":"Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.","volume":"27","author":"Elliott","year":"2006","journal-title":"Eur Heart J"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.106.621185","article-title":"Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry.","volume":"115","author":"Colan","year":"2007","journal-title":"Circulation"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/1573403X12666160301115543","article-title":"Clinical characteristics and treatment of cardiomyopathies in children.","volume":"12","author":"Price","year":"2016","journal-title":"Curr Cardiol Rev"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ehjci\/jeac233","article-title":"Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy.","volume":"24","author":"Hermida","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0022-5223(96)70018-1","article-title":"Obstructive hypertrophic cardiomyopathy in pediatric patients: results of surgical treatment.","volume":"112","author":"Theodoro","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2016.01.071","article-title":"The mitral valve in obstructive hypertrophic cardiomyopathy: a test in context.","volume":"67","author":"Sherrid","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.110.985812","article-title":"Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.","volume":"124","author":"Maron","year":"2011","journal-title":"Circulation"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1161\/01.CIR.0000072343.81530.75","article-title":"Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.","volume":"107","author":"Maron","year":"2003","journal-title":"Circulation"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jacc.2012.07.071","article-title":"Research on children with hypertrophic cardiomyopathy.","volume":"61","author":"Salberg","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjcard.2022.06.007","article-title":"Ventricular septal myectomy for obstructive hypertrophic cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC expert panel.","volume":"180","author":"Maron","year":"2022","journal-title":"Am J Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:00:21Z","timestamp":1746316821000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036034","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]}}}